Kawasaki Disease
📧 Sign up to get email alerts when something new happens for Kawasaki Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2021-03-12Clinical Trial Update: Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Disease [Phase 3]
Phase 3 trial of immunoglobulin plus infliximab for Kawasaki Disease was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-02-17Clinical Trial Update: Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease [Phase 2]
A Phase 2 study of canakinumab in pediatric patients with Kawasaki disease has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-05-24Clinical Trial Update: Cardiovascular Risk Markers and Response to Statins After Kawasaki Disease [Phase 2]
A Phase 2 clinical trial evaluating cardiovascular risk markers and statin response after Kawasaki disease was withdrawn.